|
| Exchange Disseminated Time 12/08/2015 18:24:04 | Natco Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 12, 2015, inter alia, has approved the following items and recommended to the members for their approval in the ensuing Annual General Meeting:
1. Sub-division of face value of equity shares of the Company from Rs. 10/- (rupees ten only) each to that of Rs. 2/- (rupees two only) each.
2. Increase of remuneration of Working Directors
3. Enhancement of Limits of Borrowing Powers
4. Creation of Security / Charge on the properties of the Company. |
|
|